Cargando…

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma

Lung cancer is the leading cause of cancer-related deaths worldwide. Hypoxia is a crucial microenvironmental factor in lung adenocarcinoma (LUAD). However, the prognostic value based on hypoxia and immune in LUAD remains to be further clarified. The hypoxia-related genes (HRGs) and immune-related ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hua, Zhu, Guangsheng, Shi, Ruifeng, Li, Yongwen, Zhang, Zihe, Xu, Songlin, Chen, Chen, Cao, Peijun, Pan, Zhenhua, Zhang, Hongbing, Liu, Minghui, Liu, Hongyu, Chen, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174870/ https://www.ncbi.nlm.nih.gov/pubmed/35711827 http://dx.doi.org/10.7150/jca.70725

Ejemplares similares

Identification of small proline‐rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis
por: Zhang, Zihe, et al.
Publicado: (2021)

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy
por: Cao, Peijun, et al.
Publicado: (2023)

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
por: Cao, Peijun, et al.
Publicado: (2022)

Construction of a circular RNA–microRNA–messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis
por: Li, Yongwen, et al.
Publicado: (2021)

LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma
por: Li, Xuanguang, et al.
Publicado: (2023)

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
por: Li, Ying, et al.
Publicado: (2021)

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
por: Gong, Hao, et al.
Publicado: (2020)

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer
por: Li, Weiting, et al.
Publicado: (2021)

Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
por: Li, Yongwen, et al.
Publicado: (2018)

Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma
por: Hui, Hongliang, et al.
Publicado: (2023)

Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
por: Gao, Min, et al.
Publicado: (2023)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors
por: Liu, Minghui, et al.
Publicado: (2016)

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer
por: Gao, Min, et al.
Publicado: (2023)

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2022)

HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer
por: Liu, Minghui, et al.
Publicado: (2018)

Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells
por: Pan, Zhenhua, et al.
Publicado: (2022)

Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and in vitro and in vivo validation
por: Zhou, He, et al.
Publicado: (2023)

Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
por: Dong, Yunlong, et al.
Publicado: (2020)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Development and validation of a prognostic classifier based on HIF-1 signaling for hepatocellular carcinoma
por: Deng, Feiwen, et al.
Publicado: (2020)

Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma
por: Chen, Qirui, et al.
Publicado: (2023)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model
por: Zhou, Lei, et al.
Publicado: (2023)

Prognostic Modeling of Lung Adenocarcinoma Based on Hypoxia and Ferroptosis-Related Genes
por: Liu, Chang, et al.
Publicado: (2022)

Hypoxia classifier for transcriptome datasets
por: Puente-Santamaría, Laura, et al.
Publicado: (2022)

Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)
por: Li, Xin, et al.
Publicado: (2020)

Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma
por: Lv, Shaohua, et al.
Publicado: (2022)

Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia
por: Sun, Kang, et al.
Publicado: (2023)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism–Related Genes in Gastric Cancer
por: Wei, Xiao-Li, et al.
Publicado: (2021)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Pterostilbene mediates glial and immune responses to alleviate chronic intermittent hypoxia-induced oxidative stress in nerve cells
por: Liu, Peijun, et al.
Publicado: (2023)

Development and validation of a hypoxia-related prognostic signature for breast cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5vdivokq842p5ee409p29tckl0